Development of a highly sensitive monoclonal antibody-based indirect competitive enzyme-linked immunosorbent assay for the detection of avilamycin in feed.
Food Addit Contam Part A Chem Anal Control Expo Risk Assess
; 39(3): 488-498, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35061576
An indirect competitive enzyme-linked immunosorbent assay (ic-ELISA) was developed using a highly sensitive and specific monoclonal antibody against avilamycin. The immunising antigen synthesised through the carbonyldiimidazole (CDI) method was used to prepare antibodies. The established ic-ELISA, after optimisation of conditions, possessed a half maximum inhibitory concentration (IC50) value of 7.44 ng mL-1 and the detection limit of 0.21 ng mL-1 in the standard curve. The spiked experiments indicated that the limits of detection were 1.86 µg kg-1 and 2.31 µg kg-1 in swine feed and chicken feed, respectively. In addition, the average recoveries ranged from 74.7 to 105.4% with the coefficient of variation less than 11%. The good correlation (R2 = 0.9818) between the result of ic-ELISA and HPLC demonstrated the reliability of the developed ic-ELISA, which showed that the ic-ELISA developed here achieves the aim of strengthening the monitoring of avilamycin residues and the inspection of import and export related products.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligosaccharides
/
Antibodies, Monoclonal
Type of study:
Diagnostic_studies
Limits:
Animals
Language:
En
Journal:
Food Addit Contam Part A Chem Anal Control Expo Risk Assess
Journal subject:
CIENCIAS DA NUTRICAO
Year:
2022
Document type:
Article
Country of publication:
Reino Unido